Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Merck indefinite-Lived Intangible Assets — In-Process R&D (IPR&D) Carrying Value ($M) ($M)
Form 10-K Note 8 Goodwill and Other Intangibles
Latest, FY2025
427
Period ended Dec 31, 2025
Change on a year earlier
-0.7%
430 in FY2024
History
4 years
Since FY2022
Sources
3
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Indefinite-Lived Intangible Assets — In-Process R&D (IPR&D) Carrying Value ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 427 | -0.7% | Form 10-K (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 430 | -93.7% | Form 10-K (filed 2026-02-24) ↗ |
| FY2023 | Dec 31, 2023 | 6,816 | -11.0% | Form 10-K (filed 2025-02-25) ↗ |
| FY2022 | Dec 31, 2022 | 7,661 | – | Form 10-K (filed 2024-02-26) ↗ |
Cite this data
StockData. (2026). Merck Indefinite-Lived Intangible Assets — In-Process R&D (IPR&D) Carrying Value ($M) ($M), annual FY2022–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/intang_iprd_net
See every metric in the Merck KPI table. Data updated Oct 26, 2026.